logo
logo

New Lung Cancer Breathalyzer Provides Greater Chance Of Successfully Curing Disease

avatar
Keith Brewton
img

The new technology has been developed by Cambridge-based Owlstone Medical and uses a tiny microchip sensor which can measure the volatile organic compounds in the the patient s exhaled breath.

Current techniques often involved using large, room-sized pieces of equipment and can take a long period of time to produce an accurate result.

Gladden Willis via Getty Images

Co-founder and CEO of Owlstone Medical Billy Boyle believes that now they can effectively shrink the technology they ll be overcome many of the barriers that prevent effective treatment of the disease.

Only 10 per cent of those diagnosed live for more than five years, and it s believed that late diagnosis plays a key role in that statistic.

Before the biopsy each patient will then do a breath test, the biopsy will then be carried out and the results compared.

While Boyle sees his breathalyzer making it into GP surgeries, he has even greater ambitions for the technology.

collect
0
avatar
Keith Brewton
guide
Zupyak is a free content platform for publishing and discovering stories, software and startups.